9M20 Sales & Profit Margin Overview

2019 Quarter 1 2020 %Chg. 2019 Quarter 2 2020 9M20: Consolidated Income Statement Highlight 9 Months 2020 Quarter 3 Net sales 125,286 138,135 10% Gross Profit Margin 14.1% 18.3% 13.9% 133,897 143,805 18.1% % Chg. 7% 2019 EBIT 5,979 12,355 107% 5,106 EBIT Margin 4.8% 8.9% 3.8% 13,174 9.2% 158% 2020 132,597 157,805 13.5% 19.1% 5,085 15,357 3.8% 9.7% %Chg. 19% 2019 %Chg. 13.8% 391,780 439,745 18.5% 12% 202% 16,170 40,886 4.1% 9.3% 153% EBITDA EBITDA Margin G/L on FV of Biological Assets Share in Profit of Associates Financial Costs Income Taxes Expense (687) NET PROFIT 4,279 11,585 9.2% (1,431) (1,762) 2,348 2,680 (3,414) (3,665) (1,996) 6,111 19,224 66% 10,590 20,063 89% 13.9% 7.9% 14.0% 8.2% 10,871 22,371 14.2% 106% 33,046 61,658 87% 8.4% 14.0% -23% 124 962 676% 644 321 -50% (663) (479) 28% 14% 7% 1,870 (3,467) 191% (1,172) 43% 4,105 1,583 (4,491) (2,919) 6,028 -15% 30% 149% 47% 2,260 2,028 (3,380) (4,186) (1,400) (2,998) 6,062 7,475 -10% 6,478 6,291 -3% 24% (10,261) (12,342) 20% 114% 23% (3,259) (7,913) 14,445 19,614 143% 36% EPS (THB) 0.50 0.73 0.48 0.72 # of capital shares 8,185 8,185 8,185 8,171 Paid-Up Capital 8,611 8,611 8,611 8,611 Dividend (THB/Share) Note: (1) # of capital shares = No. of the weighted-avg. shares 0.72 0.91 1.71 2.35 8,185 8,076 8,185 8,144 8,611 8,611 8,611 8,611 0.30 0.40 (2) One time expense from the amendment of the Thailand's Labour Protection Act in the amount of THB 2, 126 m in 2019 (3) Financial costs includes impact from the adoption of TFRS 16, interest on lease liabilities in the amount of THB 1,561 m in 9M20 P.14

View entire presentation